Back to JONES FINANCIAL COMPANIES LLLP JONES FINANCIAL COMPANIES LLLP

BCLIBCLI
3 quarters

Position history for JONES FINANCIAL COMPANIES LLLPJONES FINANCIAL COMPANIES LLLP's holdings in BrainStorm Cell Therapeutics In

JONES FINANCIAL COMPANIES LLLP previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$257

Total Shares Change

-216

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
Unchanged
216
0.0%
$2290.0%$1.06
0
2025-Q1
New
216
-
$2570.0%$1.19
17

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used